SCIENTIFIC PUBLICATIONS
User Notes
- GRX-917 is deuterated (metabolically improved) etifoxine, with an identical mechanism of action
- Click any research or file name below and the original study or file will appear in a separate browser
- Additional files or data can be requested by emailing the CSO: [email protected]
Clinical Studies of Etifoxine in Anxiety
Comparisons to Benzodiazepines
1. Compared etifoxine to clonazepam (Klonopin®) – established non-inferiority in GAD, panic and various phobias
3. Compared etifoxine to alprazolam (Xanax®) – for safety and efficacy
4. Compared etifoxine with lorazepam (Ativan®) – for sedative and amnesic effects
Comparison to a Serotonergic
Additional
8. Etifoxine Leads to Relief of Anxiety, Pain and Joint Syndrome
Stresam® Labeling and Marketing Materials
Pre-Clinical Studies of Etifoxine: Anxiety & Other Indications
1. Etifoxine for Arthritis Pain
2. Etifoxine and Analgesic Strategies
3. Analgesic and Anti-Edemic Properties of Etifoxine
5. Etifoxine for Neuropathic Pain
6. Etifoxine for Mononeuropathy
7. Etifoxine Causes Neurosteroid Biosynthesis
8. Etifoxine Increases Neurosteroid Levels
9. Etifoxine Causes Neurosteroid Biosynthesis at TSPO
10. Etifoxine During Spinal Nociceptive Processing
11. Etifoxine for Axonal Regeneration and Neuroinflammation
12. Etifoxine Preventive and Curative Effects in Brain Edema
12. Etifoxine Improves Peripheral Nerve Regeneration and Functional Recovery
13. Etifoxine Protects Against Cerebral Ischemia/Reperfusion Injury (Stroke)
14. Etifoxine is Protective in Multiple Sclerosis
15. Etifoxine for Treating Age-Related Macular Degeneration (Retinal)